Evaluating the clinical utility of measuring levels of factor H and the related proteins
P Banerjee, BRJ Veuskens, EG de Jorge, M Józsi… - Molecular …, 2022 - Elsevier
After years of disappointing clinical results, the tide has finally changed and complement
targeted-therapies have become a validated and accepted treatment option for several …
targeted-therapies have become a validated and accepted treatment option for several …
Evaluating the clinical utility of measuring levels of factor H and the related proteins
P Banerjee, B Veuskens, EG de Jorge… - Molecular …, 2022 - pubmed.ncbi.nlm.nih.gov
After years of disappointing clinical results, the tide has finally changed and complement
targeted-therapies have become a validated and accepted treatment option for several …
targeted-therapies have become a validated and accepted treatment option for several …
Evaluating the clinical utility of measuring levels of factor H and the related proteins
P Banerjee, B Veuskens, EG de Jorge… - Molecular …, 2022 - research.rug.nl
After years of disappointing clinical results, the tide has finally changed and complement
targeted-therapies have become a validated and accepted treatment option for several …
targeted-therapies have become a validated and accepted treatment option for several …
Evaluating the clinical utility of measuring levels of factor H and the related proteins
P Banerjee, BRJ Veuskens… - Molecular …, 2022 - epub.uni-regensburg.de
After years of disappointing clinical results, the tide has finally changed and complement
targeted-therapies have become a validated and accepted treatment option for several …
targeted-therapies have become a validated and accepted treatment option for several …
Evaluating the clinical utility of measuring levels of factor H and the related proteins
P Banerjee, B Veuskens… - … - archiv.ub.uni-marburg.de
After years of disappointing clinical results, the tide has finally changed and complement
targeted-therapies have become a validated and accepted treatment option for several …
targeted-therapies have become a validated and accepted treatment option for several …
Evaluating the clinical utility of measuring levels of factor H and the related proteins.
P Banerjee, B Veuskens, EG de Jorge… - Molecular …, 2022 - europepmc.org
After years of disappointing clinical results, the tide has finally changed and complement
targeted-therapies have become a validated and accepted treatment option for several …
targeted-therapies have become a validated and accepted treatment option for several …